Russell Singleton Email & Phone Number

Provide consulting services to complex medical device companies to help them overcome hurdles in product development and general management such as: team dynamics particularly in internal/external communication, projects missing deadlines, lower than desired innovation, difficulty in identifying/acquiring the right talent/leadership skills.

Shifted to a new role to identify emerging technologies for acquisition and conduct due diligence. Relocated back to SF Bay Area.

• From success in interim role, hired to lead transformation of R&D culture into a lean, collaborative organization focused on managing scale and execution while continually innovating.
• Led team in developing 5 new product releases, with eight FDA 510(k) clearances (no U.S. human clinical data required).
• Team created a next-gen robotic systems concept-car prototype to stimulate investment in nine months.
• Inspired innovation that resulted in 140+ new issued/allowed/pending patents, a significant increase from original base of 60.
• Mentored team and produced several top performers and inspired leaders who continue to advance.
• Positioned team for multiple Edison, Medical Design Excellence, Red Herring, Frost & Sullivan, and Popular Science Awards.

• Recruited to jumpstart stalled efforts to secure CE Mark of flagship product, Flex Robotic System. Commuted weekly from San Francisco Bay Area to Greater Boston Area.
• Engaged existing cross-functional engineering and product development teams in resetting objectives to finalize product. Reprioritized projects, focused on critical task review, created micro-project teams, and put.
• Successfully attained CE Mark by board’s March 2014 deadline (with original 60% confidence factor) after business had failed at this for previous three years.

• Served in interim C-suite leadership and advisory roles for startup and growing medical equipment and instrumentation companies.
• NovaRay Medical, Inc., Interim COO (2011 – 2013): Supported CEO in raising capital. Enabled successful partnership with China-based medical company.
• Enlumen Bio, Inc (2012-2013) – Advisor to CEO of Life Science Tools company to support recruiting, and infrastructure decisions capacity.
• Image32, aka Interconnect Medical (2011-2013) – Advise business strategy to founder/CTO of an early-stage, healthcare-IT company creating a HIPPA compliant portal for physicians to confer using mobile devices. Was.
• Predictive Medical Technology, Inc (2010-2013) – Advise business strategy to founder/CTO of an early-stage, healthcare-IT company pioneering real-time, predictive diagnostics for ICU surveillance.
• Xradia, Inc (2010) – Performed due diligence in angiogenesis and vascularization segments for a micro CT business. (acquired by Carl Zeiss in 2013)

• Pioneer in the development of predictive molecular diagnostics for MS patients using proprietary software technology. Recruited as first full-time CEO to transform company from research focus to delivery of.
• Took on accountability for all day-to-day operations and built seasoned executive team and board of directors.
• Raised bridge financing round to support shift in product development and growth strategies toward the MS market.
• As the economic downturn continued, served as face of the company leading divestiture and exit from core projects.

Amsterdam, Noord-Holland, NL

• Formerly ADAC Labs, specializing in nuclear medicine imaging equipment and radiation therapy systems; purchased by Royal Philips in 2000. Recruited to lead turnaround of previously acquired SPECT equipment business.
• Quickly evaluated people, processes, metrics, relationships, and systems. Restructured executive team with a focus on growth markets and rapidly scaling product development to drive a successful commercial launch.
• Drove completion of first system platform which realized a sales backlog by first install. Release was considered the best product in 11 years in quality and clinical usability. Won second place in AuntieMinnie.
• Accelerated development of next-gen product, elevating market share from 22% to 40%+.

US

• Bioinformatics startup providing information services to pharmaceutical companies. Recruited to consolidate and integrate all engineering and operations functions as company refined offering and value proposition.
• Drove 100% increase in productivity, enhancing delivery of critical information and services to support 20+ ongoing projects.
• Led technology deployment of operations and knowledge exchange in Japan to support transfer of 30 GB of data daily.

Milpitas, California, US

• Formerly known as KLA-Tencor. Changed name in 2019. Global capital equipment company that supplies process control and yield management systems for the semiconductor industry. Recruited back by CEO to lead startup.
• Created startup and grew business. This growth catalyzed the subsequent merger of KLA and Tencor.
• Led turnarounds of Watcher Division (from marginal profitability to consistent 35% EBITDA), Yield Management Software Division (from 30% loss to positive EBITDA and 21% revenue growth), and Software Integration.

Phd, Electrical Engineering

Certificate, Management Of High Technology Companies, Aea | Stanford University Executive Institute

Ms, Electrical Engineering

B.Eng., Electrical